期刊文献+

肠黏膜细胞因子在肠易激综合征患者回肠及升结肠组织中的表达 被引量:12

Expression of IL-6,IL-23 and TGF-β1 in the mucosa of the ileum and ascending colon of patients with irritable bowel syndrome: an analysis of 110 cases
下载PDF
导出
摘要 目的:研究肠易激综合征(IBS)患者回肠末端及升结肠黏膜组织中炎性因子白介素(IL)-6、IL-23及TGF-β1的表达,探讨IBS的发病机制.方法:选取110例IBS患者,另选40例健康体检者为对照,内镜下取回肠及升结肠肠黏膜组织各1块,用免疫组织化学法测定回肠末端及升结肠肠黏膜中IL-6、IL-23及TGF-β1水平.结果:IL-6及IL-23在IBS患者回肠末端及升结肠肠黏膜的表达高于对照组(IL-6:106.45±12.54vs82.45±11.52,t=10.58;107.48±18.75vs91.32±10.45,t=5.16;IL-23:10.68±3.35vs4.78±2.54,t=10.12;11.42±2.87vs5.20±1.85,t=12.76,均P<0.05);TGF-β1在I B S患者回肠末端及升结肠肠黏膜的表达与对照组比较差异无统计学意义(t=1.57,1.69,P>0.05).结论:IBS患者回肠黏膜及升结肠炎性细胞因子表达水平升高,促炎细胞因子与抑炎细胞因子失衡,与IBS内脏感知及排便习惯的改变等症状的发生有一定相关性. AIM:To investigate the expression of interleukin(IL)-6,IL-23 and transforming growth factor beta1(TGF-β1)in the mucosa of the ileum and ascending colon of patients with irritable bowel syndrome(IBS).METHODS:One hundred and ten patients with IBS and 40 healthy volunteers were included in the study.Mucosal samples were taken from the ileum and ascending colon of these subjects to detect the expression of IL-6,IL-23 and TGF-β1 by immunohistochemistry.RESULTS:The expression levels of IL-6 and IL-23 in the mucosa of the ileum and ascending colon were higher in IBS patients than in controls(IL-6:106.45±12.54 vs 82.45±11.52,t =10.58;107.48±18.75 vs 91.32±10.45,t=5.16;IL-23:10.68±3.35 vs 4.78±2.54,t=10.12;11.42± 2.87 vs 5.20±1.85,t=12.76,all P0.05).No significant difference was found in the expression level of TGF-β1 in the mucosa of the ileum and ascending colon between the two groups(t=1.57,1.69,both P0.05).CONCLUSION:High expression of proinflammatory cytokines in the mucosa of the ileum and ascending colon may have a correlation with visceral perception and altered bowel habits in patients with IBS.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第10期1085-1088,共4页 World Chinese Journal of Digestology
关键词 肠易激综合征 细胞因子 白介素 转化生长因子β1 Irritable bowel syndrome Cytokine Interleukin Transforming growth factorβ1
  • 相关文献

参考文献19

  • 1Ohman L, Isaksson S, Lundgren A, Simren M, Sjovall H. A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3:980-986.
  • 2陈浩,柯美云.肠易激综合征与炎症关系的研究现状[J].国际消化病杂志,2007,27(3):172-174. 被引量:14
  • 3李延青,张海燕,左秀丽,袁海鹏,卢雪峰,李君曼.肠易激综合征患者肠黏膜Th1/Th2漂移的研究[J].中华消化杂志,2004,24(12):728-731. 被引量:74
  • 4Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-1479.
  • 5功能性胃肠病的罗马Ⅲ诊断标准[J].现代消化及介入诊疗,2007,12(2):137-140. 被引量:299
  • 6Borowiec AM, Fedorak RN. The role of probiotics in management of irritable bowel syndrome. Curr Gastroenterol Rep 2007; 9:393400.
  • 7刘雁冰,刘菲,袁耀宗.肠道炎症与肠易激综合征[J].国外医学(消化系疾病分册),2004,24(6):326-329. 被引量:17
  • 8鞠辉,刘希双,王光兰,尹晓燕,刘华,戴素美.感染后肠易激综合征与溃疡性结肠炎缓解期患者肠黏膜细胞因子表达的相关性[J].世界华人消化杂志,2007,15(8):844-848. 被引量:6
  • 9Dinah TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, O'Mahony S, Shanahan F, Keeling PW. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006; 130:304-311.
  • 10Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-725.

二级参考文献71

  • 1张茹,王福贤.肠易激综合征患者IL-8和TNF-α含量变化的意义[J].临床消化病杂志,2004,16(4):167-168. 被引量:31
  • 2李延青,张海燕,左秀丽,袁海鹏,卢雪峰,李君曼.肠易激综合征患者肠黏膜Th1/Th2漂移的研究[J].中华消化杂志,2004,24(12):728-731. 被引量:74
  • 3王巍峰,杨云生,孙刚,彭丽华.肠易激综合征大鼠P物质能神经通路的改变[J].世界华人消化杂志,2005,13(2):214-218. 被引量:22
  • 4肖海刚,郭津生.细菌性痢疾与肠易激综合征相关性分析[J].世界华人消化杂志,2006,14(10):1012-1014. 被引量:7
  • 5Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut, 2000, 47:804-811.
  • 6Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology,2002, 122:1178-1783.
  • 7Monteleone I, Vavassori P, Biancone L, et al. Immunoregulation in the gut: successs and failures in human disease. Gut, 2002, 50(suppl Ⅲ ): Ⅲ60-Ⅲ64.
  • 8Isgar B, Harman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut, 1983, 24: 190-192.
  • 9Diagnostic criteria for functional gastrointestinal disorders. In:Drossman DA, Corazziari E, Talley NJ, eds. Rome Ⅱ: the functional gastrointestinal disorders. 2nd ed. USA Allen Press, 2000.659-668.
  • 10Collins SM, Piche T, Rampal P. The putative role of inflammation in the irritable bowel syndrome. Gut, 2001, 49:743-745.

共引文献401

同被引文献124

引证文献12

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部